Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.
2.

Stranger in a Strange Land: IL-8 in the Mouse Lung?

Worgall S.

Am J Respir Cell Mol Biol. 2018 Nov;59(5):525-526. doi: 10.1165/rcmb.2018-0206ED. No abstract available.

PMID:
30095972
3.

Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.

Burg N, Swendeman S, Worgall S, Hla T, Salmon JE.

Arthritis Rheumatol. 2018 Nov;70(11):1879-1889. doi: 10.1002/art.40558.

PMID:
29781582
4.

Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.

Gomi R, Sharma A, Wu W, Sung B, Worgall S.

Vaccine. 2017 Dec 18;35(51):7174-7180. doi: 10.1016/j.vaccine.2017.10.078. Epub 2017 Nov 7.

5.

Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma.

Stone A, Novetsky Friedman D, Worgall S, Kushner BH, Wolden S, Modak S, LaQuaglia MP, Wu X, Cheung NK, Sklar CA.

J Pediatr Hematol Oncol. 2017 Oct;39(7):547-554. doi: 10.1097/MPH.0000000000000883.

6.

Distinct Serum Sphingolipid Profiles among School-aged Children with Exercise-induced Wheeze and Asthma Persistence.

Perzanowski MS, Ono JG, Acosta LM, Kim BI, Divjan A, Miller R, Rundle A, Worgall S, Worgall TS.

Am J Respir Crit Care Med. 2017 Apr 15;195(8):1068-1070. doi: 10.1164/rccm.201609-1884LE. No abstract available.

7.

Regulation of the Coxsackie and adenovirus receptor expression is dependent on cystic fibrosis transmembrane regulator in airway epithelial cells.

Sharma A, Xu Y, Sung B, Vincent CT, Worgall T, Worgall S.

Cell Microbiol. 2017 Feb;19(2). doi: 10.1111/cmi.12654. Epub 2016 Sep 16.

PMID:
27527752
8.

Cost Associated With Pediatric Delirium in the ICU.

Traube C, Mauer EA, Gerber LM, Kaur S, Joyce C, Kerson A, Carlo C, Notterman D, Worgall S, Silver G, Greenwald BM.

Crit Care Med. 2016 Dec;44(12):e1175-e1179.

9.

The fermentation product 2,3-butanediol alters P. aeruginosa clearance, cytokine response and the lung microbiome.

Nguyen M, Sharma A, Wu W, Gomi R, Sung B, Hospodsky D, Angenent LT, Worgall S.

ISME J. 2016 Dec;10(12):2978-2983. doi: 10.1038/ismej.2016.76. Epub 2016 May 14.

10.

Mast cells and exosomes in hyperoxia-induced neonatal lung disease.

Veerappan A, Thompson M, Savage AR, Silverman ML, Chan WS, Sung B, Summers B, Montelione KC, Benedict P, Groh B, Vicencio AG, Peinado H, Worgall S, Silver RB.

Am J Physiol Lung Cell Mol Physiol. 2016 Jun 1;310(11):L1218-32. doi: 10.1152/ajplung.00299.2015. Epub 2016 Apr 29.

11.

Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology.

Sharma A, Wu W, Sung B, Huang J, Tsao T, Li X, Gomi R, Tsuji M, Worgall S.

J Virol. 2016 Apr 29;90(10):5068-5074. doi: 10.1128/JVI.00259-16. Print 2016 May 15.

12.

Airway reactivity and sphingolipids-implications for childhood asthma.

Ono JG, Worgall TS, Worgall S.

Mol Cell Pediatr. 2015 Dec;2(1):13. doi: 10.1186/s40348-015-0025-3. Epub 2015 Dec 4.

13.

New Developments in Cystic Fibrosis Airway Inflammation.

Palaniyar N, Mall MA, Taube C, Worgall S, Grasemann H.

Mediators Inflamm. 2015;2015:769425. doi: 10.1155/2015/769425. Epub 2015 Jun 29. No abstract available.

14.

Chronic Infection by Mucoid Pseudomonas aeruginosa Associated with Dysregulation in T-Cell Immunity to Outer Membrane Porin F.

Quigley KJ, Reynolds CJ, Goudet A, Raynsford EJ, Sergeant R, Quigley A, Worgall S, Bilton D, Wilson R, Loebinger MR, Maillere B, Altmann DM, Boyton RJ.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1250-64. doi: 10.1164/rccm.201411-1995OC.

15.

Decreasing mean airway pressure as a management strategy for tension pneumatocoeles.

Wellington AC, Spigland NA, Worgall S, Groves AM.

Arch Dis Child Fetal Neonatal Ed. 2015 Mar;100(2):F101. doi: 10.1136/archdischild-2014-307405. Epub 2014 Nov 13. No abstract available.

PMID:
25395470
16.

Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection.

Sharma A, Wendland R, Sung B, Wu W, Grunwald T, Worgall S.

Vaccine. 2014 Sep 29;32(43):5761-8. doi: 10.1016/j.vaccine.2014.08.049. Epub 2014 Aug 26.

17.

Annexin A2 mediates secretion of collagen VI, pulmonary elasticity and apoptosis of bronchial epithelial cells.

Dassah M, Almeida D, Hahn R, Bonaldo P, Worgall S, Hajjar KA.

J Cell Sci. 2014 Feb 15;127(Pt 4):828-44. doi: 10.1242/jcs.137802. Epub 2013 Dec 19.

18.

17q21 locus and ORMDL3: an increased risk for childhood asthma.

Ono JG, Worgall TS, Worgall S.

Pediatr Res. 2014 Jan;75(1-2):165-70. doi: 10.1038/pr.2013.186. Epub 2013 Oct 28. Review.

PMID:
24165737
19.

Editorial: RSV, dendritic cells, and allergens--a bad combination.

Worgall S.

J Leukoc Biol. 2013 Jul;94(1):1-3. doi: 10.1189/jlb.0113024. No abstract available.

20.

Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity.

Worgall TS, Veerappan A, Sung B, Kim BI, Weiner E, Bholah R, Silver RB, Jiang XC, Worgall S.

Sci Transl Med. 2013 May 22;5(186):186ra67. doi: 10.1126/scitranslmed.3005765. Erratum in: Sci Transl Med. 2013 Jul 3;5(192):192er7.

21.

Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.

Rosenberg JB, De BP, Hicks MJ, Janda KD, Kaminsky SM, Worgall S, Crystal RG.

Hum Gene Ther. 2013 Jun;24(6):595-603. doi: 10.1089/hum.2012.245.

22.

RGD capsid modification enhances mucosal protective immunity of a non-human primate adenovirus vector expressing Pseudomonas aeruginosa OprF.

Krause A, Whu WZ, Qiu J, Wafadari D, Hackett NR, Sharma A, Crystal RG, Worgall S.

Clin Exp Immunol. 2013 Aug;173(2):230-41. doi: 10.1111/cei.12101.

23.

Mast cells: a pivotal role in pulmonary fibrosis.

Veerappan A, O'Connor NJ, Brazin J, Reid AC, Jung A, McGee D, Summers B, Branch-Elliman D, Stiles B, Worgall S, Kaner RJ, Silver RB.

DNA Cell Biol. 2013 Apr;32(4):206-18. doi: 10.1089/dna.2013.2005.

24.

Adenovirus-based vaccine with epitopes incorporated in novel fiber sites to induce protective immunity against Pseudomonas aeruginosa.

Sharma A, Krause A, Xu Y, Sung B, Wu W, Worgall S.

PLoS One. 2013;8(2):e56996. doi: 10.1371/journal.pone.0056996. Epub 2013 Feb 20.

25.

Fungal sensitization in childhood persistent asthma is associated with disease severity.

Vicencio AG, Santiago MT, Tsirilakis K, Stone A, Worgall S, Foley EA, Bush D, Goldman DL.

Pediatr Pulmonol. 2014 Jan;49(1):8-14. doi: 10.1002/ppul.22779. Epub 2013 Feb 8.

PMID:
23401301
26.

Low sphingosine-1-phosphate impairs lung dendritic cells in cystic fibrosis.

Xu Y, Krause A, Limberis M, Worgall TS, Worgall S.

Am J Respir Cell Mol Biol. 2013 Feb;48(2):250-7. doi: 10.1165/rcmb.2012-0021OC. Epub 2012 Dec 13.

27.

40 years on: have we finally got a vaccine for Pseudomonas aeruginosa?

Worgall S.

Future Microbiol. 2012 Dec;7(12):1333-5. doi: 10.2217/fmb.12.106. No abstract available.

28.

Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.

De BP, Pagovich OE, Hicks MJ, Rosenberg JB, Moreno AY, Janda KD, Koob GF, Worgall S, Kaminsky SM, Sondhi D, Crystal RG.

Hum Gene Ther. 2013 Jan;24(1):58-66. doi: 10.1089/hum.2012.163. Epub 2012 Dec 21.

29.

Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging.

Dyke JP, Sondhi D, Voss HU, Shungu DC, Mao X, Yohay K, Worgall S, Hackett NR, Hollmann C, Yeotsas ME, Jeong AL, Van de Graaf B, Cao I, Kaminsky SM, Heier LA, Rudser KD, Souweidane MM, Kaplitt MG, Kosofsky B, Crystal RG, Ballon D.

AJNR Am J Neuroradiol. 2013 Apr;34(4):884-9. doi: 10.3174/ajnr.A3297. Epub 2012 Oct 4.

30.

AAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessation.

Hicks MJ, Rosenberg JB, De BP, Pagovich OE, Young CN, Qiu JP, Kaminsky SM, Hackett NR, Worgall S, Janda KD, Davisson RL, Crystal RG.

Sci Transl Med. 2012 Jun 27;4(140):140ra87. doi: 10.1126/scitranslmed.3003611.

31.

AAVrh.10-mediated expression of an anti-cocaine antibody mediates persistent passive immunization that suppresses cocaine-induced behavior.

Rosenberg JB, Hicks MJ, De BP, Pagovich O, Frenk E, Janda KD, Wee S, Koob GF, Hackett NR, Kaminsky SM, Worgall S, Tignor N, Mezey JG, Crystal RG.

Hum Gene Ther. 2012 May;23(5):451-9. doi: 10.1089/hum.2011.178.

32.

Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization.

Ding BS, Nolan DJ, Guo P, Babazadeh AO, Cao Z, Rosenwaks Z, Crystal RG, Simons M, Sato TN, Worgall S, Shido K, Rabbany SY, Rafii S.

Cell. 2011 Oct 28;147(3):539-53. doi: 10.1016/j.cell.2011.10.003.

33.
34.

Recent developments for Pseudomonas vaccines.

Sharma A, Krause A, Worgall S.

Hum Vaccin. 2011 Oct;7(10):999-1011. doi: 10.4161/hv.7.10.16369. Epub 2011 Oct 1. Review.

35.

Chemical scaffolds with structural similarities to siderophores of nonribosomal peptide-polyketide origin as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis.

Ferreras JA, Gupta A, Amin ND, Basu A, Sinha BN, Worgall S, Jayaprakash V, Quadri LE.

Bioorg Med Chem Lett. 2011 Nov 1;21(21):6533-7. doi: 10.1016/j.bmcl.2011.08.052. Epub 2011 Aug 26.

36.

Absence of vaccine-enhanced RSV disease and changes in pulmonary dendritic cells with adenovirus-based RSV vaccine.

Krause A, Xu Y, Ross S, Wu W, Joh J, Worgall S.

Virol J. 2011 Jul 29;8:375. doi: 10.1186/1743-422X-8-375.

37.

Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.

Krause A, Whu WZ, Xu Y, Joh J, Crystal RG, Worgall S.

Vaccine. 2011 Mar 3;29(11):2131-9. doi: 10.1016/j.vaccine.2010.12.087. Epub 2011 Jan 6.

38.

Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.

Hicks MJ, De BP, Rosenberg JB, Davidson JT, Moreno AY, Janda KD, Wee S, Koob GF, Hackett NR, Kaminsky SM, Worgall S, Toth M, Mezey JG, Crystal RG.

Mol Ther. 2011 Mar;19(3):612-9. doi: 10.1038/mt.2010.280. Epub 2011 Jan 4.

39.

Delivery of antigens by viral vectors for vaccination.

Krause A, Worgall S.

Ther Deliv. 2011 Jan;2(1):51-70. Review.

PMID:
22833925
40.

Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.

Shiratsuchi T, Rai U, Krause A, Worgall S, Tsuji M.

J Clin Invest. 2010 Oct;120(10):3688-701. doi: 10.1172/JCI39812. Epub 2010 Sep 1.

41.

Gene therapy for late infantile neuronal ceroid lipofuscinosis: neurosurgical considerations.

Souweidane MM, Fraser JF, Arkin LM, Sondhi D, Hackett NR, Kaminsky SM, Heier L, Kosofsky BE, Worgall S, Crystal RG, Kaplitt MG.

J Neurosurg Pediatr. 2010 Aug;6(2):115-22. doi: 10.3171/2010.4.PEDS09507.

42.

Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.

Xu Y, Krause A, Hamai H, Harvey BG, Worgall TS, Worgall S.

PLoS One. 2010 Jun 8;5(6):e11004. doi: 10.1371/journal.pone.0011004.

43.

Overexpression of sonic Hedgehog in the lung mimics the effect of lung injury and compensatory lung growth on pulmonary Sca-1 and CD34 positive cells.

Krause A, Xu Y, Joh J, Hubner R, Gess A, Ilic T, Worgall S.

Mol Ther. 2010 Feb;18(2):404-12. doi: 10.1038/mt.2009.229. Epub 2009 Oct 27.

44.

Expression of B-cell activating factor enhances protective immunity of a vaccine against Pseudomonas aeruginosa.

Tertilt C, Joh J, Krause A, Chou P, Schneeweiss K, Crystal RG, Worgall S.

Infect Immun. 2009 Jul;77(7):3044-55. doi: 10.1128/IAI.00927-08. Epub 2009 Apr 13.

45.

Influence of the cystic fibrosis transmembrane conductance regulator on expression of lipid metabolism-related genes in dendritic cells.

Xu Y, Tertilt C, Krause A, Quadri LE, Crystal RG, Worgall S.

Respir Res. 2009 Apr 3;10:26. doi: 10.1186/1465-9921-10-26.

46.

Emphysema mediated by lung overexpression of ADAM10.

Saitoh H, Leopold PL, Harvey BG, O'Connor TP, Worgall S, Hackett NR, Crystal RG.

Clin Transl Sci. 2009 Feb;2(1):50-6. doi: 10.1111/j.1752-8062.2008.00085.x.

47.

Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.

Skaricic D, Traube C, De B, Joh J, Boyer J, Crystal RG, Worgall S.

Virology. 2008 Aug 15;378(1):79-85. doi: 10.1016/j.virol.2008.04.016. Epub 2008 Jun 16.

48.

Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.

Worgall S, Sondhi D, Hackett NR, Kosofsky B, Kekatpure MV, Neyzi N, Dyke JP, Ballon D, Heier L, Greenwald BM, Christos P, Mazumdar M, Souweidane MM, Kaplitt MG, Crystal RG.

Hum Gene Ther. 2008 May;19(5):463-74. doi: 10.1089/hum.2008.022.

PMID:
18473686
49.

Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF.

Worgall S, Krause A, Qiu J, Joh J, Hackett NR, Crystal RG.

J Virol. 2007 Dec;81(24):13801-8. Epub 2007 Oct 17.

50.

Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imaging.

Dyke JP, Voss HU, Sondhi D, Hackett NR, Worgall S, Heier LA, Kosofsky BE, Uluğ AM, Shungu DC, Mao X, Crystal RG, Ballon D.

AJNR Am J Neuroradiol. 2007 Aug;28(7):1232-6.

Supplemental Content

Loading ...
Support Center